K Phos Tablet, Coated
NDC Package 0486-1125-01
Package Information
K Phos (sodium phosphate, dibasic, anhydrous, potassium phosphate, monobasic, and sodium phosphate, monobasic, monohydrate) tablets is k-PHOS® NEUTRAL increases urinary phosphate and pyrophosphate. This formulation utilizes a tablet, coated delivery system. Marketed by Beach Products, Inc., this product is identified by NDC 0486-1125.
Identification & Billing
- RxCUI: 1251241 - K-Phos Neutral 852 MG / 155 MG / 130 MG Oral Tablet
- RxCUI: 1251241 - potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG Oral Tablet [K-Phos Neutral]
- RxCUI: 1251241 - K+ phosphate 155 MG / Sodium Phosphate, Dibasic 852 MG / Sodium Phosphate, Monobasic 130 MG Oral Tablet [K-Phos Neutral]
- RxCUI: 1251241 - K-Phos Neutral (phosphorus 250 MG / sodium 298 MG (13 MEQ) / potassium 45 MG (1.1 MEQ)) Oral Tablet
- RxCUI: 1251241 - K-Phos Neutral (potassium phosphate 155 MG / sodium phosphate, dibasic 852 MG / sodium phosphate, monobasic 130 MG) Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0486 - Beach Products, Inc.
- 0486-1125 - K Phos
- 0486-1125-01 - 100 TABLET, COATED in 1 BOTTLE
- 0486-1125 - K Phos
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0486-1125). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0486-1125-01 identifies a specific commercial package of 100 tablet, coated in 1 bottle of K Phos Neutral, a human prescription drug labeled by Beach Products, Inc.. This tablet, coated is formulated for oral use and contains potassium phosphate, monobasic; sodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Beach Products, Inc. on April 11, 1977. The current certification is valid through December 31, 2026.
How is this Beach Products, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00486112501. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.